Results 171 to 180 of about 76,404 (302)

A Case of Splenectomy [PDF]

open access: yesBMJ, 1889
J. Dreschfeld   +2 more
openaire   +3 more sources

How we manage immune‐mediated thrombotic thrombocytopenic purpura after rituximab failure or intolerance

open access: yesBritish Journal of Haematology, Volume 206, Issue 6, Page 1560-1570, June 2025.
The use of rituximab as a pre‐emptive treatment in immune‐mediated thrombotic thrombocytopenic purpura (iTTP) is the current standard of care. However, for patients refractory to rituximab or for those with contraindication, further treatment guidelines are scarce.
Julia Weisinger   +4 more
wiley   +1 more source

Aplastic Anæmia Treated by Splenectomy [PDF]

open access: bronze, 1945
M D M Shaw, Leslie Oliver
openalex   +1 more source

Examining the secret life of the spleen in sickle cell disease

open access: yes
HemaSphere, Volume 9, Issue 6, June 2025.
Adama Ladu, Stephen P. Hibbs
wiley   +1 more source

Splenectomy in Infants and Children*

open access: green, 1955
L Walter, Lawrence Chaffin
openalex   +2 more sources

Acute splenomegaly, haemolysis, and thrombocytopenia following luspatercept initiation in a patient with transfusion‐dependent thalassaemia: A case report

open access: yesBritish Journal of Haematology, Volume 206, Issue 6, Page 1806-1810, June 2025.
Summary Patients with transfusion‐dependent thalassaemia (TDT) require chronic, life‐sustaining red blood cell transfusions, which contribute to iron overload and associated morbidity and mortality. Luspatercept, an inhibitor of the transforming growth factor‐beta pathway, decreases transfusion requirements in a subset of transfusion‐dependent β ...
Bianca Zaidel   +2 more
wiley   +1 more source

Splenectomy for Acholuric Jaundice [PDF]

open access: bronze, 1914
W. Essex Wynter, John Bland‐Sutton
openalex   +1 more source

Organoids in Haematologic Research: Advances and Future Directions

open access: yesCell Proliferation, Volume 58, Issue 6, June 2025.
This review focuses on the advancements in organoid technology and its transformative role in haematological research, particularly in the modelling of haematopoietic tissues, blood diseases and drug development. It also offers an outlook on the future prospects of organoids in personalised medicine and the study of disease mechanisms.
Liangzheng Chang   +4 more
wiley   +1 more source

Defining Targets for Continuous Glucose Monitoring After Total Pancreatectomy With Islet Autotransplantation

open access: yesClinical Transplantation, Volume 39, Issue 6, June 2025.
ABSTRACT Introduction Targets for continuous glucose monitoring (CGM) are well established for type 1 and type 2 diabetes. In total pancreatectomy with islet autotransplantation (TPIAT), stricter glycemic targets are needed to avoid metabolic stress on transplanted islets, but no guidelines exist for CGM targets.
Zaynab Somani   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy